Skip to main
SYK

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 27%
Buy 47%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is currently facing a slowing momentum in their product cycles, slower adoption in certain settings, and potential disruption from a recent cyberattack. However, the company has a strong competitive position in the market and potential for growth through market expansion and acquisitions. There is also a risk of lower-than-expected growth in certain procedure categories due to increased competition. Overall, while there are some challenges facing the company, there is potential for long-term growth and a positive outlook for the stock.

Bears say

Stryker is facing stiff competition in the market for orthopedic robotics systems, as several competitors are ramping up their own programs with new and differentiated products. Slow adoption within the ASC setting could limit the company's long-term growth potential, and the recent cyberattack could potentially have a material impact on the company's near-term results and outlook. There are also concerns about the potential for slowing momentum from recent product cycles, lack of execution in growth-accretive M&A, and tariff and macro headwinds. However, Stryker's leadership position in the orthopedic implant market, its strong growth potential in the MedSurg and Neurotechnology segment, and its consistently strong commercial execution could potentially help drive outperformance and multiple expansion in the future.

Stryker (SYK) has been analyzed by 15 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 47% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 15 analysts, Stryker (SYK) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $396.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $396.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.